DefiniGEN Licenses Lung Stem Cell Technology From University of Cambridge – Lung Disease News
|
DefiniGEN Licenses Lung Stem Cell Technology From University of Cambridge
Lung Disease News DefiniGEN Ltd, a worldwide producer of products and services related to stem cell technology, recently announced that its IP portfolio is now much stronger thanks to the addition of a license for a cutting edge lung stem cell technology developed at … |
